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Abstract 
The aim of this study was to improve the stability  and antioxidant activity of yarrow phenolic 
compounds upon an in vitro simulated gastrointestinal digestion. Therefore, two types of 
caseins-based delivery systems, sodium caseinate stabilized nanoemulsions (NEs) and glucono 
delta-lactone acidified milk gels (MGs), were formulated containing an ultrasound-assisted 
yarrow extract (YE) at two concentrations (1 and 2.5 mg/mL). Formulations with 1 mg/mL of 
YE were chosen based on their higher encapsulation efficiency to perform the in vitro digestion 
experiments. After digestion, YE-loaded NEs only partially protected phenolic compounds 
from degradation; meanwhile the phenolic composition of YE including in MGs after digestion 
was quite similar to undigested YE. Moreover, the antioxidant activity of MGs after digestion 
was higher than NEs digested samples, which confirms the higher protection of YE phenolic 
compound by the milk gels systems.  
This research demonstrated the potential use of acidified MGs as carriers to improve the 
stability  and antioxidant activity of yarrow phenolic compounds.  Therefore, these matrices 
could be employed to develop new dairy products enriched with phenolic compounds.  
Abbreviations 
NEs, nanoemulsions, MGs, milk gels; YE, yarrow extract; EtOH; ethanol; UAE, Ultrasound-
Assisted Extraction; HPH, high pressure homogenization; NaCas, sodium caseinate; GDL; 
glucono delta-lactone; Gʹ, storage modulus; Gʺ; loss modulus; tan δ, loss tangent value; EE, 
encapsulation efficiency; PVDF, polyvinylidene fluoride; TEAC, Trolox equivalent antioxidant 




Achillea millefolium L., commonly known as yarrow, has been traditionally used to treat 
gastrointestinal and hepatobiliary disorders, inflammation or diabetes (Akram, 2013). The 
bioactivity of aqueous and ethanolic  yarrow extracts has been associated with the presence of 
phenolic compounds, mainly phenolic acids and flavones (Villalva et al., 2019 ). Nevertheless, 
after oral consumption, the potential health benefits of phenolics compounds could be limited 
due to instability under certain pH conditions, poor water solubility, gastrointestinal enzyme 
degradation, low intestinal permeability or metabolism during digestion (Karakaya, 2004 ). 
Thus, phenolic stability during gastrointestinal digestion has been related to their chemical 
structure; for instance, the presence or absence of glycosylation, the glycosylation patterns, etc. 
(Czubinski et al., 2019). Besides, alkaline medium of small intestine has been also described as 
an important parameter in phenolic compounds stability reduction (Chen et al., 2014). 
Moreover, digestive enzymes were reported to accelerate the hydroxylation of phenolics after 
gastric digestion phase (Barak, Celep, Inan & Yesilada, 2019). Therefore, oral administration 
of these compounds requires strategies to preserve their chemical integrity and successful 
delivery in physiological targets.  
In recent years, the encapsulation of phenolics compounds as a strategy to reduce the 
undesirable changes in these compounds during gastrointestinal transit has been extensively 
studied (Ghayour et al., 2019; Velderrain-Rodríguez, Acevedo-Fani, González-Aguilar & 
Martín-Belloso, 2019). Thus, several encapsulation techniques (e.g., spray drying, emulsion, 
inclusion complexation), as well as carrier materials (e.g., chitosan, soy proteins, glucan, etc.), 
have already been proposed for phenolic compounds (Chen, Gnanaraj, Aurulselvan, El-Seedi 
& Teng, 2019; Esfanjani, Assadpour & Jarafi, 2018; Ozkan, Franco, De Marco, Xiao & 
Capanoglu, 2019 ). The encapsulation of phenolic compounds like quercetin, oleuropein, 
resveratrol and tea polyphenols by different techniques and using several carriers, provided an 
increase in their stability and bioaccessibility after gastrointestinal process (González et al., 
2019; Jayan, Leena, Sundari & Moses, 2019; Liang et al., 2017; Yan et al., 2018).   
Ideally, food-grade encapsulation materials, as proteins, are selected to formulate food 
products. Proteins have multiple applications in encapsulation matrices of phenolic compounds, 
as emulsifiers, gelling agents and also as entities to formulate micro and nano-particles (Jia, 
Dumont & Orsat, 2016; Foegeding, Plundrich, Schneider, Campell & Lila, 2017). The ability 
of phenolic compounds to associate with milk proteins is well documented, particularly to 
proline-rich proteins such as α- and β-caseins through hydrophobic interactions and hydrogen 
bonds (Chanphai, Bourassa, Kanakis, Tarantilis & Polissiou, 2018). Thus, this ability has been 
used to develop delivery carriers. Ghayour at al. (2019) proposed the nanoencapsulation of 
quercetin and curcumin by using caseins in order to design protein-based delivery systems to 
incorporate these compounds to beverages. Arranz et al. (2019) also employed casein matrices 
as carriers for rosmarinic acid delivery in food product development.. 
Nanoemulsion-based encapsulation systems for phenolic compounds have been well 
established, due to its high efficacy encapsulation, maintenance of chemical stability and 
controlled release (Artiga-Artigas, Lanjari-Pérez & Martín-Belloso, 2018; Lu, Kelly & Miao, 
2016). In order to develop these systems, sodium caseinate  has been described as a food grade 
emulsifier that improves delivery of phenolic compounds. Sabouri, Arranz, Guri & Corredig 
(2018)  indicated that the incorporation of epigallocatechin-gallate (EGCG) in sodium caseinate 
emulsions improved its bioaccessibility and preserved its functional properties during 
gastrointestinal digestion. Besides, Casanova et al. (2018) also reported a complexation of 
cyaniding-3-O-glucoside with sodium caseinate, suggesting that sodium caseinate is a potential 
carrier for anthocyanins. 
The gelation of protein matrices has also been indicated as an alternative method to encapsulate 
phenolic compounds (Jia et al., 2016). Caseins have excellent gelation properties and have been 
proposed as carriers for phenolic compounds since they are able to interact with phenolics, form 
complexes and entrap them through their gelation process (Ozdal, Capanoglu & Alta, 2013). 
Thus, Bayraktar, Harbourne & Fagan (2019) showed that polyphenols extracts (green tea and 
white grape) and simple phenolic compounds (tannic and gallic acids) could be successfully 
used to develop acidified dairy products with antioxidant properties. Moreover, Trigueros, 
Wojdylo & Sendra (2014) also reported that in yogurts containing pomegranate juice, most of 
anthocyanins were bound to casein fraction.  
The aim of this study was first to evaluate the stability of yarrow phenolic compounds after in 
vitro simulated gastrointestinal digestion. Then, two different casein-based delivery systems 
were developed and characterized; as a strategy to improve yarrow phenolic compounds 
stability  and antioxidant activity after simulated digestion. 
 
2. Materials and methods 
2.1 Reagents and chemicals  
Ethanol (EtOH) (99.5% purity) was obtained from Panreac (Barcelona, Spain). Formic acid 
(99%) was obtained from Acros Organics (Madrid, Spain) and acetonitrile HPLC grade from 
Macron Fine Chemicals (Madrid, Spain). (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-
carboxylic acid (Trolox, 97%) and 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) were 
purchased from Sigma-Aldrich (Madrid, Spain). Reference standards (HPLC purity ≥95%) for 
phenolic compounds identification such as chlorogenic acid, diosmetin and vitexin were 
purchased from Sigma-Aldrich. 1,5-Diccafeoylquinic acid (DCQA), 3,4-DCQA, 3,5-DCQA, 
4,5-DCQA, apigenin, luteolin, orientin, schaftoside and vicenin 2 were obtained from Phytolab 
(Madrid, Spain). Apigenin-7-O-glucoside, caffeic acid, homoorientin, luteolin-7-O-β-glucoside 
and rutin were from Extrasynthese S.A. (Genay, France). The water used in this study was 
ultrapure type 1 (Millipore, Madrid, Spain). 
 
2.2. Yarrow samples and Ultrasound-Assisted Extraction (UAE) 
Achillea millefollium L. (yarrow) was obtained from an herbalist´s local supplier (León, Spain). 
The sample included inflorescences and upper dried leaves of the plant (water content less than 
5%). The plant was ground using a Premill 250 hammer mill (Leal S.A., Granollers, Spain) and 
sieved to the appropriate size (<500 µm). The extraction process was performed by UAE in an 
ultrasonic device (Branson digital sonifier 450, Danbury, USA) at 400 W and 60 kHz. Ethanol 
was used as extraction solvent (1:10 plant/solvent ratio) during 30 min at 40 ºC and an output 
of 50% nominal amplitude. Ethanol was evaporated in a rotary evaporator (IKA®, Werke GmbH 
and Co., KG, Germany) and samples were stored at −20ºC until use.  
 
2.3. Chemical characterization of phenolic compounds 
Phenolic chromatographic analyses were conducted in an Agilent 1260 Infinity series HPLC-
PAD (Santa Clara, CA, USA). A reverse phase ACE Excel 3 Super C18 column (150 mm x 4.6 
mm, 3 m particle size) from ATC (Aberdeen, Scotland, UK) equipped with a pre-column from 
the same material was employed according to the chromatographic method reported by Villalva 
et al. (2018). Besides, accurate mass from HPLC-PAD-QTOF-MS/MS in a negative mode 
analysis was used for compounds identification (Villalva et al., 2018). Quantification of 
identified compounds was performed using calibration curves of pure analytical standards. In 
addition, luteolin-di-hexoside and 6-hydroxyluteolin-7-O-glucoside were quantified by the 
calibration curves of orientin and luteolin-7-O-glucoside respectively. Correspondingly, 
apigenin glycosylated derivative were quantified using apigenin-7-O-glucoside calibration 
curve and schaftoside isomer and apigenin-hexoside-pentoside respect to schaftoside 
calibration curve.  
 
2.4. Preparation and characterization of yarrow extract (YE)-loaded nanoemulsions (NEs). 
NEs were prepared using high pressure homogenization (HPH). Oil in water emulsions, 
containing 7% of soybean oil (w/w) (Sigma Aldrich, Oakville, ON, Canada) and a YE stock 
solution (dissolved in less than 1% of EtOH) to achieve 0, 1 or 2.5 mg/mL in final emulsion, 
were formulated with 2% sodium caseinate (NaCas) (New Zealand Milk Proteins, Mississauga, 
ON, Canada) as emulsifier. Initially, NaCas was dispersed in ultrapure water with magnetic 
stirrer and stored overnight at 4ºC to allow complete hydration. Emulsions were prepared by 
addition of YE to soybean oil and subsequent incorporation of NaCas solution. Both phases 
were pre-homogenized using a Polytron mixer (Brinkmann Inst. Corp., Mississauga, ON, 
Canada) at 30,000 RPM for 2 min, and then HPH was performed at 450 kPa for five passes 
using a microfluidizer (model M-110Y, Microfluidics Corporation, Newton, MA, USA). Then 
NEs were characterized (particle size and -potential) and stored under refrigeration at 4ºC for 
two weeks in order to evaluate its stability. 
The particle size distribution was measured using static light scattering (Mastersizer 2000, 
Malvern Instruments, Worcestershire, UK), with water as dispersant. The refractive indices 
were 1.33 and 1.47, for water and soybean oil, respectively. Mean particle diameter was 
reported as the volume-weighted mean diameter (d4,3) calculated as the average of triplicate 
measurements. Zeta ()-potential was determined by dynamic light scattering (DLS) (Zetasizer 
Nano, Malvern Instruments, Malvern, UK) in samples diluted in ultrapure grade water at 1:500 
ratio. All measures were done by triplicate.  
 
2.5. Preparation and characterization of milk gels (MGs) of yarrow extract 
Pasteurised skimmed milk, acidified with 2% (w/w) of glucono delta-lactone (GDL) (Sigma 
Aldrich) and containing a YE stock solution to obtain 0, 1 or 2.5 mg/mL in final gels, was used 
to prepare MGs. Initially, a suspension of heated (85ºC for 30 min) or non-heated milk with YE 
was stirred for 1 hour at room temperature and protected from direct light. Then, this suspension 
was warmed up to 30ºC, the GDL was added, and the mixture was kept at 30ºC for 180 min. 
After milk gelation, the samples were stored at 4ºC until analyses.  
The dynamic rheological measurements were performed by applying a constant strain of 0.05% 
at a frequency of 1 Hz by means of a Physica MCR301 stress-controlled rheometer (Anton-
Paar, Graz, Austria) using a concentric cylinder with solvent trap cover, at 30°C. The gelation 
point was taken at the time of cross-over between Gʹ (storage modulus) and Gʺ (loss modulus) 
(Haratifar & Corredig, 2014). In parallel, the pH was monitored during milk gel formation using 
an Accumet pH meter (Fisher Scientific, Edmonton, Canada). All experiments were done by 
triplicate. 
 
2.6. Encapsulation efficiency of phenolic compounds 
The encapsulation efficiency (EE) of yarrow phenolic compounds in NEs and MGs was 
measured after centrifugation of fresh samples for 1 h (60.000 g (NEs) and 20.500 g (MGs), 
respectively). Aqueous phase were recovered and filtered using 0.22 m polyvinylidene 
fluoride (PVDF) filters prior injection in a HPLC-PAD. Analysis was performed as previously 
described in section 2.3.  
Encapsulation efficiency of individual phenolic compounds (individual EE%) was determined 
by Eq. 1 and the total encapsulation efficiency (total EE%) of the formulation was calculated 
by Eq. 2, as followed: 
 
Eq. (1) 
Individual 𝐸𝐸(%) = [1 −  
𝐼𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙  𝑝ℎ𝑒𝑛𝑜𝑙𝑖𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑖𝑛 𝑎𝑞𝑢𝑒𝑢𝑠 𝑝ℎ𝑎𝑠𝑒
𝐼𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙  𝑝ℎ𝑒𝑛𝑜𝑙𝑖𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑞𝑢𝑎𝑛𝑡𝑖𝑓𝑖𝑒𝑑 𝑖𝑛 𝑒𝑥𝑡𝑟𝑎𝑐𝑡





2.7. In vitro simulated gastrointestinal digestion 
A two steps in vitro simulated digestion, gastric and intestinal, was performed according to a 
standardised protocol (Minekus et al., 2014), with slight modifications, suited to the food matrix 
being analysed (Arranz et al., 2017). Briefly, 10 mL of each sample were mixed with 10 mL of 
simulated gastric fluids containing 25,000 U/mL of pepsin, 0.2 mL of HCL (1 M) and 5 µL of 
CaCl2 (0.3 M) at a final pH 3 in amber jars. Samples were incubated in a shaking water bath 
(220 strokes/min) (New Brunswick Scientific Co., Inc., NJ, USA) for 30 min at 37°C. Then, 20 
mL of simulated intestinal fluids were incorporated containing 5.0 mg/mL of pancreatin (800 
U/mL), 160 mM bile salts, 40 µL of CaCl2, (0.3 M), 0.15 ml of NaOH (1 M), 1 mM 
phospholipids and 5 µL phospholipase A2 (stock solution 6.7 mg/mL), and the mixture was 
incubated for 2 h at 37 °C and pH 7. At the end of the digestion, the enzyme reaction was 
immediately stopped by keeping the samples on ice and stored at −20 °C. Samples (4 mL) were 
then freeze-dried for further experiments. Digestion process was performed by triplicate for 
every formulation (free YE, YE-NEs and YE-MGs). In addition, control digestions without YE 
(water, NEs and MGs) were performed.  
For quantification of phenolic compounds after digestion, digested freeze-dried samples were 
re-suspended in 1 mL of EtOH and acidified water with 0.1% formic acid (60:40, v/v). Later, 
the mixture was placed into an ultrasound water-bath (5 min) and centrifuged at room 
temperature (4,500 RPM, 5 min). The clear supernatant was filtered using 0.45 m PVDF filters 
prior analysis by HPLC-PAD as described in 2.3 section. 
 
Total 𝐸𝐸(%) = [
∑ 𝐸𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑒𝑑 𝑝ℎ𝑒𝑛𝑜𝑙𝑖𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑s 
𝑇𝑜𝑡𝑎𝑙 𝑝ℎ𝑒𝑛𝑜𝑙𝑖𝑐 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑𝑠 𝑖𝑛 𝑒𝑥𝑡𝑟𝑎𝑐𝑡
]  𝑥 100  
2.8. Antioxidant activity 
2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) method was applied according to Brand-
Williams, Cuvelier & Berset (1995), with some modifications. Briefly, a volume of 975 µL of 
6.1 x 10-5 M DPPH• methanol solution was used. The reaction was started by adding 25 µL of 
sample or blank. The bleaching of DPPH• was followed at 517 nm at room temperature until 
the reaction was completed (3 h). All the samples were prepared at 4 different concentrations, 
by triplicate, to obtain the inhibition curve of DPPH•. The results were calculated as mmol 
Trolox equivalent/g extract (TEAC value). Analysis was done by triplicate. 
 
2.9. Statistical analysis 
For each sample, experiments were performed at least by triplicate and expressed as mean 
values and standard deviation. A one-way analysis of variance (ANOVA) followed by LSD test 
(Fisher’s least significant difference) post-test were used to discriminated significant 
differences between means at p <0.05. Analysis was performed using Statgraphic v. Centurion 
XVI package for Windows (Statpoint Inc., Warrenton, VA, USA).  
 
3. Results and discussion 
3.1. Effect of in vitro simulated gastrointestinal digestion on YE phenolic compounds 
Phenolic compounds characterization of YE, before and after in vitro simulated gastrointestinal 
digestion, was performed by HPLC-PAD analysis (Table 1). Therefore, twenty-one phenolic 
compounds were identified in YE, mainly glycosylated flavonoids and phenolic acids. The 
main compounds were 3,5-dicaffeoylquinic acid (DCQA) and luteolin-7-O-glucoside, followed 
by vicenin 2 and an apigenin glycosylated derivate. These phenols represented 49% of the total 
phenolic compounds quantified in YE. Other caffeoylquinic acid derivatives like chlorogenic 
acid and 4,5-DCQA were found in representative amounts within the phenolic acids in YE. 
Glycosylated flavones like 6-hydroxyluteolin-7-O-glucoside and schaftoside, besides its 
isomers, were also identified. These results were consistent with previously reported studies of 
yarrow extracts (Benedek, Gjoncaj, Saukei & Kopp, 2007; Pereira et al., 2018). 
The quantitative analysis of phenolic fraction of YE after digestion showed that the 
concentration of almost all detected compounds was modified. Several authors indicated that 
the stability of phenolic compounds during the gastrointestinal digestion process is strongly 
influenced by their chemical structure, since phenolics have a different sensitivity to pH 
variations and digestive enzymes activity (Goulas & Hadjisolomou, 2019; Lima et al., 2019). 
Regarding the main components of the extract, 3,5-DCQA concentration was highly reduced 
after digestion (from 17.0 ± 0.47 to 5.84 ± 0.28 mg/g of extract), while 3,4-DCQA and 4,5-
DCQA were increased. In fact, 4,5-DCQA was the main compound in the digested extract. 
These results suggest an isomerization of 3,5-DCQA towards 3,4-DCQA and 4,5-DCQA in pH 
conditions occurring during digestion. Similarly, D’Antuono, Garbetta, Linsalata, Minervini & 
Cardinali (2015) also detected an isomerization effect  after gastrointestinal digestion of 3,5-
DCQA (pure individual compound) with the presence of 4,5- and 3,4-DCQAs after intestinal 
step. Luteolin-7-O-glucoside, the second most abundant compound in YE, was also reduced in 
approx. 25%, after digestion. This reduction has been generally attributed to the instability of 
flavonoid glycosides under pH values of small intestine, where several modifications such as 
oxidation and polymerization might occur (Celep, Akyüz, Inan & Yesilada, 2018). Therefore, 
the encapsulation of YE phenolic compounds in delivery systems could be an useful strategy 
to improve their stability during gastrointestinal digestion. 
 
3.2. Formulation and characterization of YE-loaded nanoemulsions (NEs)  
YE-loaded NEs with two different concentrations of YE, 1mg/mL (NE-1.0) and 2.5 mg/mL 
(NE-2.5), were formulated in soy oil in NaCas water emulsions. NEs control, without YE, was 
also formulated.  
The particle size distribution (Fig. 1) indicated that the control emulsion had a monomodal 
distribution. This distribution did not change after YE incorporation, although NE-2.5 showed 
a wider size distribution than control and NE-1.0. Freshly prepared control emulsion (day 0) 
had a mean particle diameter (d4,3) of 248 ± 1.0 nm (Table 2). The addition of YE did not modify 
the emulsions particle diameter. All NEs had a negative net surface charge (-potential), with 
no statistical differences between the control and YE-loaded NEs.  
The physical stability of YE-loaded NEs was monitored during two weeks. The values of mean 
particle diameter and -potential after 7 and 14 days of storage at 4ºC are shown in Table 2. 
After 14 days, no statistical differences were observed neither in the mean particle diameter nor 
in the -potential of any formulation. These data denote the stability of YE-loaded NEs. Thus, 
caseinate stabilized nanoemulsions containing tea polyphenols (epigallocatechin-gallate) 
showed a mean particle diameter and -potential values quite similar to those found in this study 
(Sabouri et al., 2015). Besides, Sharma et al. (2017) also reported that a clove nanoemulsion 
stabilized with sodium caseinate presented a similar mean particle diameter and -potential. 
This emulsion was found to be stable for 20 days.  
 
3.3. Formulation and characterization of acidified milk gels (MGs) including YE  
Milk gels including two different concentrations of YE, 1mg/mL (MG-1.0) and 2.5 mg/mL 
(MG-2.5), were prepared using heated or unheated milk, acidified with GDL. Control MGs 
(without YE) were also formulated.  
MGs formulated with heated milk showed a shorter gelation time and higher pH values at 
gelation time than those obtained with unheated milk (Table 3). Heated MGs also showed 
higher final storage modulus (Gʹ) values than those formulated with unheated milk (Table 3), 
indicating that heated gels presented a higher stiffness at the end of the acidification process. 
Besides, the final loss tangent values (tan δ were significantly lower for heated gels. At 
moderate heating temperatures (70-90ºC), whey proteins unfold and associate with casein 
micelles. During acidification, these unfolded-associated proteins act as a cross-link between 
protein particles and increase the number (and strength) of bonds in the gel network, 
consequently higher Gʹ values are obtained, pH increases at gelation and shorter gelation times 
are required (Donato, Alexander & Dalgleish, 2007). 
Despite the differences found in the rheological properties between heated and unheated 
formulations, the addition of different concentration of YE did not significantly modify the 
gelation time, the pH at gelation time, the final G´ value or the final tan δ value (Table 3). 
Similarly, Vega & Grover (2011) formulated acidified MGs including a commercial cocoa 
extract, rich in flavanols, showing that final Gʹ values and pH values at gelation time were not 
modified with extract addition, compared to the control gel.  However, the addition of tannic 
and gallic acids to milk have resulted in faster gelation times and gels with Gʹ values higher 
than control samples (Harbourne, Jacquier & O’Riordan, 2011). These different  results could 
be explained by interactions between milk proteins and phenolic compounds and it was 
described that these interactions are highly affected by the concentration, type and structure of 
phenolic compounds employed (Ozdal et al., 2013). 
 
3.4. Encapsulation efficiency (EE) of YE phenolic compounds in NEs and MGs. 
The encapsulation efficiency of YE individual phenolic compounds in NEs and MGs is shown 
in Table 4. Regarding NEs, the encapsulation efficiency was related to the YE concentration, 
NE-1.0 showed higher EE for all the compounds than NE-2.5. Encapsulation efficiency of all 
phenolic compounds in NE-1.0 ranged from 88.1 to 100%. However, in NE-2.5 the values were 
under 55%, except for luteolin, apigenin and diosmetin. Hence, the total encapsulation 
efficiency calculated in NE-1.0 was significantly higher than in NE-2.5 (92.3 ± 4.6% vs. 33.7 
± 0.9% respectively).These results could be explained since at a concentration of 1 mg/mL, 
most YE phenolic compounds were binding sodium caseinate at the oil-water interface. 
However, the concentration of 2.5 mg/mL could saturated interaction sites in protein chain, due 
to the polyphenol/protein ratio was too high. Consequently, a high quantity of phenolic 
compounds was non-encapsulated and presented in the aqueous phase. 
Regarding MGs, the encapsulation efficiency was also affected by the concentration of YE, but 
in a lesser extent than in NEs. Thus, MG-1.0 had a total encapsulation efficiency of 72.0 ± 
2.7%, meanwhile MG-2.5 showed a 63.1 ± 2.6%. In MGs formulations, apigenin and luteolin 
glycosylated forms presented a lower EE than their aglycone forms. Thus, Xiao et al. (2011) 
also indicated that the glycosylation of flavonoids lowered their affinity for milk proteins. These 
authors endorsed the decrease of affinity after glycosylation to the non-planar structure, since 
molecules with near-planar structure can easily enter the hydrophobic pockets in proteins. 
However, this decrease in EE of glycosylated forms could be also related to their lower 
hydrophobicity, with respect to non-glycosylated forms. Among phenolic acids, the DCQAs 
showed higher encapsulation efficiency than chlorogenic and caffeic acids. DCQAs higher 
encapsulation could be related to the higher hydrophobicity of DCQAs (with respect to 
chlorogenic and caffeic acids), that induces a stronger association between proteins and 
polyphenols (Adrar, Madani & Adrar, 2019). Nevertheless, their different structures (size, 
length and flexibility) could also affect protein-phenolic compounds interactions.  
3.5 Effect of in vitro digestion on YE phenolic compounds included NEs and MGs. 
Formulations with 1 mg/mL of YE (NE-1.0 and MG-1.0) were chosen based on their higher EE 
to perform in vitro digestion experiments. The quantitative analysis of individual phenolic 
compounds was performed after gastrointestinal digestion (Table 1). The quantification of 
phenolic compounds after NE-1.0 digestion showed that the digestion process modifies their 
concentration, but in a lower extent than when free yarrow extract was digested. Moreover, 10 
of the 21 phenolic compounds detected in digested NE-1.0 decreased their concentration 
(compared to undigested YE), meanwhile after free YE digestion the quantity of 16 compounds 
were reduced. Regarding 3,5-DCQA, the most abundant compound in YE, a 3.4 times 
decreased was observed when free YE was digested versus 1.6 times reduction with NE-1.0. 
Luteolin-7-O-glucoside’s concentration was only reduced from 7.57 ± 0.17 to 6.51 ± 0.10 mg/g 
of sample when NE-1.0 was employed. These results suggested that some encapsulated 
compounds in NEs were partially released and exposed to digestion conditions, indicating that 
the formulation of YE-loaded NEs only partially protected the YE phenolic compounds during 
gastrointestinal transit. The effect of gastric digestion on NaCas stabilized emulsions was 
previously reported. Li, Ye, Lee, & Singh (2012) described that caseinate-stabilized emulsions 
flocculate after digestion at acidic conditions (pH 1-3) due to pepsin hydrolysis over interfacial 
proteins in the droplets surface. Nevertheless, Sabouri et al. (2018) reported a higher recovery 
of EGCG (but not 100%) after digestion, when it was formulated with NaCas stabilized 
emulsions compared to water solutions. They concluded that the complexation of EGCG and 
NaCas at the interface of emulsions protected EGCG from digestive degradation.  
After MG-1.0 digestion process, most of the phenolic compounds remained stable, comparing 
to undigested YE (Table 1), except chlorogenic acid, 3,4-DCQA and 3,5-DCQA. Regarding 
3,5-DCQA, the concentration detected after MG-1.0 digestion was 15.9 ± 0.23 versus 17.0 ± 
0.26 mg/g of sample from the undigested extract. Moreover, 3,4-DCQA concentration 
increased from 1.79 ± 0.26 to 2.62 ± 0.25 mg/g of sample after digestion. These data indicated 
a possible isomerization of 3,5-DCQA to 3,4-DCQA during digestion. This isomerization was 
also found in the digestion of the free YE (non-encapsulated), but in a greater extent. 
These findings are in line with the protection effect of YE phenolic compounds against 
degradation during digestion by MGs. Indeed, Lamothe, Azimy, Bazinet, Couillard & Britten 
(2014) described that the addition of a green tea extract to a yogurt matrix significantly 
decreased the rate and extent of proteolysis in the gastric phase. They suggested that the 
formation of complexes between milk proteins and green tea polyphenols increase protein 
stability during pepsin digestion. However, they also reported that the presence of tea extract 
did not influence protein hydrolysis in the intestinal phase, with the release of 100% of the 
polyphenols initially added. They concluded that interactions between green tea polyphenols 
and milk proteins help to maintain the integrity of polyphenols during digestion. Recently, 
Adrar et al. (2019) reported that polyphenols-proteins interactions would play a certain role in 
the preservation of polyphenols structure and function through the gastrointestinal tract transit. 
Thus, MGs offered an almost complete protection of phenolic compounds during 
gastrointestinal digestion; meanwhile this protection is only partial when employing NEs. 
 
3.6 Effect of in vitro digestion on free and encapsulated YE antioxidant activity 
The antioxidant activity of undigested YE and digested samples: free YE, NE-1.0 and MG-1.0 
was evaluated (Table 5). Empty (without YE) NEs and MGs were also digested and its 
antioxidant activity was determined (0.050±0.002 and 0.078±0.003 mmol Trolox/g sample 
respectively). The values obtained with these empty formulations were subtracted from the 
formulations with the extract. The digestion process reduced almost 50% of the antioxidant 
activity of free YE samples, which could be related with the reduction in phenolic compounds 
found (Table 1). The gastrointestinal digestion of NE-1.0 also decreased the antioxidant activity 
of the samples, however, in a lesser extent than free YE solutions. These results agree with the 
partial protection provided by the NE to YE phenolic compounds. Moreover, the antioxidant 
activity of MG-1.0 after digestion was the highest compared to free YE and NE-1.0, which 
confirms the higher protection of YE phenolic compounds by the milk gels systems.  Thus, 
several authors previously reported that protein-polyphenol complexes formation preserved 
polyphenols bioactivities, including antioxidant activity (Foegeding, et al, 2017).  
  
4. Conclusions 
The quantitative analysis of YE phenolic fraction after in vitro gastrointestinal digestion 
showed that the concentration of all phenolic compounds was modified. Two types of casein-
based delivery systems, sodium caseinate stabilized NEs and GDL-acidified MGs, were 
proposed to improve stability of YE phenolic compounds during digestion process.  Recovery 
of YE phenolic compounds after digestion was significantly higher in MGs than NEs. Similarly, 
the antioxidant activity of MGs after digestion was higher compared to NEs. Thus, the 
encapsulation of yarrow phenolic compounds using acidified MGs can be proposed as a strategy 
to improve their stability during gastrointestinal digestion and consequently, enhanced their 
bioaccessibility. In addition, such matrices could be employed to develop new dairy products 
enriched with phenolic compounds. 
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Table 1. Phenolic composition of yarrow extract (YE) and digested samples: YE, NE-1.0 and MG-1.0.  
 
YE: yarrow extract. NE-1.0: YE-loaded nanoemulsions at 1 mg/mL. MG-1.0: milk gels including 1 mg/ 
mL of YE. <LOQ: below limit of quantification. S Phenolic compound identified and quantified via 
comparison with its authentic standard. * An asterisk indicates statistical differences of digested samples 
with respect to the YE undigested extract (first column). Significance level at p<0.05 with Fisher's Least 
Significant Difference (LSD) test. 
Compound 
Concentration (mg /g sample) 







Chlorogenic acid S 4.49 ± 0.20 1.24 ± 0.31* 3.03 ± 0.19* 3.28 ± 0.40* 
Vicenin 2 S 5.33 ± 0.25 4.93 ± 0.24 5.03 ± 0.32 5.09 ± 0.60 
Caffeic acid S 0.68 ± 0.22 1.09 ± 0.13* 0.63 ± 0.11 0.69 ± 0.14 
Schaftoside isomer 3.50 ± 0.07 3.27 ± 0.17 3.38 ± 0.46 3.36 ± 0.45 
Schaftoside S 3.49 ± 0.22 3.25 ± 0.30 3.43 ± 0.56  3.52 ± 0.38 
Homoorientin S 0.46 ± 0.07 0.25 ± 0.01* 0.28 ± 0.03*  0.35 ± 0.04 
Apigenin-hexoside-pentoside 2.63 ± 0.16 2.28 ± 0.19  2.54 ± 0.28 2.68 ± 0.21 
Luteolin-dihexoside 2.72 ± 0.21 2.08 ± 0.10* 2.29 ± 0.14*  2.60 ± 0.24 
6-Hydroxyluteolin-7-O-glucoside 3.67 ± 0.31 1.08 ± 0.13* 1.14 ± 0.25*  3.51 ± 0.29 
Rutin S 1.37 ± 0.28 0.86 ± 0.14* 0.98 ± 0.31 1.20 ± 0.15 
Vitexin S 0.71  ± 0.03 0.41 ± 0.05*  0.57 ± 0.02* 0.70 ± 0.07 
Apigenin glycosylated derivative 4.79 ± 0.16 4.09 ± 0.19*  4.78 ± 0.23 4.88 ± 0.20 
Luteolin-7-O-β-glucoside S 7.57 ± 0.17 5.71 ± 0.14*  6.51 ± 0.10* 7.36 ± 0.30 
3,4-diccafeoylquinic acid S 1.79 ± 0.26 4.59 ± 0.34* 3.54 ± 0.19* 2.62 ± 0.25* 
1,5-diccafeoylquinic acid S 1.91 ± 0.11 1.43 ± 0.18 1.73 ± 0.19 1.88 ± 0.25 
3,5-diccafeoylquinic acid S 17.0 ± 0.47 5.84 ± 0.28* 10.8  ± 0.11* 15.9 ± 0.23* 
Apigenin-7-O-glucoside S 2.20 ± 0.15 1.41 ± 0.08* 1.40 ± 0.25* 2.16 ± 0.26 
4,5-diccafeoylquinic acid S 3.36 ± 0.19 7.48 ± 0.13* 3.96 ± 0.14* 3.23 ± 0.28 
Luteolin S 2.15 ± 0.27 1.22 ± 0.13* 2.10 ± 0.13 2.13 ± 0.10 
Apigenin S 0.61 ± 0.13 0.24 ± 0.20* 0.50 ± 0.26 0.58 ± 0.04 
Diosmetin S 0.49 ± 0.07 <LOQ 0.35 ± 0.05* 0.44 ± 0.06 
Total phenolics 70.52 ± 4.34 52.75 ± 2.21* 57.99 ± 3.28* 68.97 ± 3.31 
Table 2. Characterization of fresh nanoemulsions (0 day) and throughout storage (7 and 14 
days). 
 
 Mean particle diameter (d 4,3) (nm)  – potential (mV)
Sample 0 d d d  0 d d d
Control  248 ± 1.0 247 ± 1.0 247 ± 1.2  -39.1 ± 0.9 -39.2 ± 1.1 -38.7 ± 0.2 
NE-1.0 250 ± 0.8 249 ± 1.2 249 ± 1.6  -38.6 ± 0.5 -38.2 ± 0.6 -37.9 ± 0.7 
NE-2.5 251 ± 2.0 251 ± 1.0 250 ± 1.0  -38.2 ± 0.7 -38.0 ± 0.9 -37.8 ± 0.7 
NE-1.0: YE-loaded NEs at 1 mg/mL.  
NE-2.5: YE-loaded NEs at 2.5 mg/mL.  
















Table 3. Properties of acidified skim milk gels formulated with heated and unheated milk.  
 Gelation time (min) pH at gelation time Final Gʹ value (Pa) Final tan δ  
Sample Heated Unheated Heated Unheated Heated Unheated Heated Unheated 
Control  27 ± 2.1a 74 ± 1.6a 5.51 ± 0.11a 5.11 ± 0.09a 424 ± 23a 15.6 ± 0.0b 0.28 ± 0.01a 0.31 ± 0.01a 
MG-1.0 27 ± 0.6a 74 ± 1.1a 5.37 ± 0.12a 5.08 ± 0.16a 397 ± 18a 15.5 ± 0.1b 0.28 ± 0.01a 0.31 ± 0.01a 
MG-2.5 26 ± 2.7a 75 ± 0.6a 5.33 ± 0.09a 5.03 ± 0.23a 389 ± 13b 14.1 ± 1.0a 0.29 ± 0.01a 0.32 ± 0.01a 
MG-1.0: milk gels with 1.0 mg/mL of YE. MG-2.5: milk gels with 2.5 mg/mL of YE. Gʹ: storage modulus 
values. tan δ loss tangent values. a,b Different superscript letters mean statistical difference among different 
formulations for each evaluated property. Significance level at p<0.05 with Fisher's Least Significant 










Table 4. Encapsulation efficiency (EE) of individual yarrow phenolic compounds presented 
in yarrow extract (YE). 
Compound 
 Encapsulation Efficiency (%) 
NE-1.0 NE-2.5 MG-1.0 MG-2.5 
Chlorogenic acid S 88.5 ± 6.8 6.6 ± 1.2 47.1 ± 7.0 28.3 ± 6.7 
Vicenin 2 S 88.3 ± 6.7 17.5 ± 1.1 34.3 ± 8.0 8.2 ± 2.3 
Caffeic acid S 89.7 ± 6.1 20.5 ± 6.9 55.0 ± 7.5 11.0 ± 5.0 
Schaftoside isomer 89.4 ± 5.9 18.9 ± 5.0 56.8 ± 2.9 25.7 ± 7.3 
Schaftoside S 88.1 ± 7.9 17.0 ± 4.7 40.9 ± 3.6 19.8 ± 2.1 
Homoorientin S 94.6 ± 4.1 34.5 ± 7.7 65.3 ± 7.0 29.5 ± 6.5 
Apigenin-hexoside-pentoside 89.9 ± 6.6 13.4 ± 2.5 33.8 ± 9.8 12.5 ± 4.8 
Luteolin-dihexoside 92.3 ± 4.8 23.5 ± 7.0 56.6 ± 2.6 25.1 ± 6.0 
6-Hydroxyluteolin-7-O-glucoside 97.0 ± 1.4 42.0 ± 5.9 74.0 ± 0.8 79.6 ± 4.5 
Rutin S 93.1 ± 3.4 20.0 ± 6.6 47.4 ± 5.4 34.0 ± 7.8 
Vitexin S 93.2 ± 3.6 36.6 ± 7.8 51.3 ± 0.5 31.8 ± 7.0 
Apigenin glycosylated derivative 91.1 ± 5.2 34.7 ± 7.9 55.0 ± 7.4 48.4 ± 4.6 
Luteolin-7-O-β-glucoside S 95.4 ± 2.8 44.5 ± 5.7 80.0 ± 3.3 73.5 ± 3.3 
3,4-diccafeoylquinic acid S 91.0 ± 7.0 22.2 ± 7.6 81.4 ± 6.1 61.9 ± 6.7 
1,5-diccafeoylquinic acid S 92.3 ± 4.9 43.0 ± 7.1 91.6 ± 1.6 85.0 ± 5.9 
3,5-diccafeoylquinic acid S 93.2 ± 4.4 36.4 ± 6.0 98.0 ± 0.2 97.0 ± 1.0 
Apigenin-7-O-glucoside S 94.4 ± 1.9 54.4 ± 7.8 89.4 ± 2.3 85.0 ± 2.9 
4,5-diccafeoylquinic acid S 93.9 ± 3.7 43.8 ± 5.0 91.6 ± 1.6 87.5 ± 1.1 
Luteolin S 97.6 ± 2.9 92.6 ± 1.1 100 ± 0.0 100 ± 0.0 
Apigenin S 99.3 ± 0.3 93.4 ± 2.8 100 ± 0.0 100 ± 0.0 
Diosmetin S 100 ± 0.0 100 ± 0.0 100 ± 0.0 100 ± 0.0 
Total %EE 92.3 ± 4.6 a 33.7 ± 0.9 b 72.0 ± 2.7 A 63.1 ± 2.6 B  
NE-1.0: YE-loaded nanoemulsion at 1.0 mg/mL. NE-2.5: YE-loaded nanoemulsion at 2.5 mg/mL. MG-
1.0.: milk gels with 1.0 mg/mL of YE. MG-2.5: milk gels with 2.5 mg/mL of YE. S Phenolic compound 
identified and quantified via comparison with its authentic standard. a,b Different lower case letters mean 
statistical difference within nanoemulsions. A,B Different super case letters mean statistical difference 












NE-1.0: YE-loaded nanoemulsions at 1 mg/mL. MG-1.0: milk gels including 1 mg/ mL of YE. a-d 






















TEAC Value (mmol Trolox/g sample) 
YE undigested 0.349 ± 0.007a 
Free YE digested 0.186 ± 0.002d 
NE-1.0 digested 0.202 ± 0.003c 
MG-1.0 digested 0.270 ± 0.005b 
Figure captions 
Figure 1. Particle size distribution of freshly (day 0) nanoemulsions in the presence or not of  
yarrow extract (YE). Control: without YE. NE-1.0: YE-loaded nanoemulsions at 1 mg/mL. NE-





























































 Casein-based delivery systems improved yarrow phenolic compounds stability  
 Nanoemulsions partially protected yarrow phenolic compounds during digestion 
 Yarrow phenolics included in acidified milk gels were protected during digestion 
 After digestion, phenolics in milk gels showed the highest antioxidant activity  
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